Figure 2.

Gastroduodenal ulcers in coxib or nonsteroidal anti-inflammatory drug treatment groups in osteoarthritis/rheumatoid arthritis patients. Gastroduodenal ulcers detected endoscopically (predominantly 3 mm in largest diameter, with depth) in coxib or NSAID treatment groups at 6 or 12 weeks in patients with osteoarthritis or rheumatoid arthritis. Data from meta-analyses and randomised trials [27-32]. Each symbol represents a treatment arm, the diameter proportional to the number of patients or subjects (inset scale).

Andrew Moore Arthritis Research & Therapy 2013 15(Suppl 3):S4   doi:10.1186/ar4176